Vol. 10 No. 1 (2021): January-December 2021

Published: 2021-12-28

Full Issue

Review

  • Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification?

    Stefan Erfurt, Meike Hoffmeister, Stefanie Oess, Katharina Asmus, Oliver Ritter, Susann Patschan, Daniel Patschan
    20-25
    DOI: https://doi.org/10.33393/jcb.2021.2327

Original research article

  • Value of clinical laboratory test for early prediction of mortality in patients with COVID-19: the BGM score

    Laura Macías-Muñoz, Robin Wijngaard, Bernardino González-de la Presa, Jose Luis Bedini, Manuel Morales-Ruiz, Wladimiro Jiménez
    1-8
    DOI: https://doi.org/10.33393/jcb.2021.2194

  • Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring

    Vittoria Barchiesi, Vittorio Simeon, Claudia Sandomenico, Monica Cantile, Dionigio Cerasuolo, Paolo Chiodini, Alessandro Morabito, Ernesta Cavalcanti
    9-13
    DOI: https://doi.org/10.33393/jcb.2021.2212

  • Pharmacokinetics of the disialoganglioside, GD2, a circulating tumor biomarker for neuroblastoma, in nonhuman primates

    Frank M. Balis, Cynthia Lester McCully, Christine M. Busch, Elizabeth Fox, Katherine E. Warren
    26-29
    DOI: https://doi.org/10.33393/jcb.2021.2329

Short communication

  • Circulating erythroblast abnormality associated with systemic pathologies may indicate bone marrow damage

    Stefan Schreier, Prapaphan Budchart, Suparerk Borwornpinyo, Wichit Arpornwirat, Wannapong Triampo
    14-19
    DOI: https://doi.org/10.33393/jcb.2021.2220